David J. Mack serves as Executive at BioXcel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David J. Mack has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 17,000 shares valued at $0.
David J. Mack currently holds 17,000 shares of BioXcel Therapeutics, Inc. (BTAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David J. Mack has been a net neutral trader of BTAI stock. They have purchased $0 and sold $0 worth of shares.
David J. Mack's most recent insider trade was on Jan 9, 2026, when they sold 17,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 30, 2025 | BTAI | $0 | Option Exercise | 1,694 | $N/A | Discretionary |
| Aug 31, 2025 | BTAI | $0 | Option Exercise | 1,693 | $N/A | Discretionary |
| Jul 31, 2025 | BTAI | $0 | Option Exercise | 1,693 | $N/A | Discretionary |